Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of Pegcetacoplan With Progression of Incomplete Retinal Pigment Epithelium and Outer Retinal Atrophy in Age-Related Macular Degeneration: A Post Hoc Analysis of the FILLY Randomized Clinical Trial.
Nittala MG, Metlapally R, Ip M, Chakravarthy U, Holz FG, Staurenghi G, Waheed N, Velaga SB, Lindenberg S, Karamat A, Koester J, Ribeiro R, Sadda S. Nittala MG, et al. Among authors: metlapally r. JAMA Ophthalmol. 2022 Mar 1;140(3):243-249. doi: 10.1001/jamaophthalmol.2021.6067. JAMA Ophthalmol. 2022. PMID: 35113137 Free PMC article. Clinical Trial.
Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy.
Wykoff CC, Rosenfeld PJ, Waheed NK, Singh RP, Ronca N, Slakter JS, Staurenghi G, Monés J, Baumal CR, Saroj N, Metlapally R, Ribeiro R. Wykoff CC, et al. Among authors: metlapally r. Ophthalmology. 2021 Sep;128(9):1325-1336. doi: 10.1016/j.ophtha.2021.02.025. Epub 2021 Mar 10. Ophthalmology. 2021. PMID: 33711380 Free article. Clinical Trial.
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Among authors: metlapally r. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
Scleral Mechanisms Underlying Ocular Growth and Myopia.
Metlapally R, Wildsoet CF. Metlapally R, et al. Prog Mol Biol Transl Sci. 2015;134:241-8. doi: 10.1016/bs.pmbts.2015.05.005. Epub 2015 Jun 12. Prog Mol Biol Transl Sci. 2015. PMID: 26310158 Free PMC article. Review.
The Association of Refractive Error with Glaucoma in a Multiethnic Population.
Shen L, Melles RB, Metlapally R, Barcellos L, Schaefer C, Risch N, Herrinton LJ, Wildsoet C, Jorgenson E. Shen L, et al. Among authors: metlapally r. Ophthalmology. 2016 Jan;123(1):92-101. doi: 10.1016/j.ophtha.2015.07.002. Epub 2015 Aug 8. Ophthalmology. 2016. PMID: 26260281 Free PMC article.
Scleral micro-RNA signatures in adult and fetal eyes.
Metlapally R, Gonzalez P, Hawthorne FA, Tran-Viet KN, Wildsoet CF, Young TL. Metlapally R, et al. PLoS One. 2013 Oct 21;8(10):e78984. doi: 10.1371/journal.pone.0078984. eCollection 2013. PLoS One. 2013. PMID: 24205357 Free PMC article.
29 results